ELDON BIOLOGICALS A/S: Financial statements 2022
CVR: 26747007
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 16,382,652 and a net result of DKK 4,971,816 compared with DKK 9,098,419 the year before. That is a decrease of 16.1% compared with the year before. Equity in the 2022 report amounted to DKK 29,619,290. The solvency ratio was 83.5%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 16,382,652
- Profit/Loss
- DKK 4,971,816
- Equity
- DKK 29,619,290
- Total Assets
- DKK 35,481,576
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 16.4 mio. | 5 mio. | 29.6 mio. | 9 |
| 2021 | - | 19.5 mio. | 9.1 mio. | 25.1 mio. | 11 |
| 2020 | - | 14.3 mio. | 6.6 mio. | 16.5 mio. | 8 |
| 2019 | - | 9.5 mio. | 3.3 mio. | 10.5 mio. | 6 |
| 2018 | - | 9.5 mio. | 3.8 mio. | 7.1 mio. | 7 |
Official annual report
Keep an eye on ELDON BIOLOGICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.